Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.690
-0.080 (-4.52%)
Dec 27, 2024, 2:32 PM EST - Market open
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $2.25 million as of December 27, 2024. Its market cap has decreased by -57.61% in one year.
Market Cap
2.25M
Enterprise Value
-5.47M
1-Year Change
-57.61%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since March 30, 2007, Palisade Bio's market cap has decreased from $82.40M to $2.25M, a decrease of -97.27%. That is a compound annual growth rate of -18.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 26, 2024 | 2.40M | -55.56% |
Dec 29, 2023 | 5.40M | -32.50% |
Dec 30, 2022 | 8.00M | -54.55% |
Dec 31, 2021 | 17.60M | 15.79% |
Dec 31, 2020 | 15.20M | 300.00% |
Dec 31, 2019 | 3.80M | -33.33% |
Dec 31, 2018 | 5.70M | -78.08% |
Dec 29, 2017 | 26.00M | -16.13% |
Dec 30, 2016 | 31.00M | -67.02% |
Dec 31, 2015 | 94.00M | -60.62% |
Dec 31, 2014 | 238.70M | 6.23% |
Dec 31, 2013 | 224.70M | 203.65% |
Dec 31, 2012 | 74.00M | 55.14% |
Dec 30, 2011 | 47.70M | -51.92% |
Dec 31, 2010 | 99.20M | 57.96% |
Dec 31, 2009 | 62.80M | 20.54% |
Dec 31, 2008 | 52.10M | -54.10% |
Dec 31, 2007 | 113.50M | 37.74% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PainReform | 2.61M |
Matinas BioPharma Holdings | 2.61M |
IMAC Holdings | 2.57M |
Aptevo Therapeutics | 2.51M |
Biodexa Pharmaceuticals | 2.49M |
Bone Biologics | 2.32M |
Phio Pharmaceuticals | 2.23M |
Akanda | 2.21M |